Casashitara

Kohei shitara (@KoheiShitara) / X

Por um escritor misterioso
Last updated 03 novembro 2024
Kohei shitara (@KoheiShitara) / X
Kohei shitara (@KoheiShitara) / X
Ravi Jaiswal, MD (@RaviJaiswal___) / X
Kohei shitara (@KoheiShitara) / X
Kohei SHITARA, Chief, Department of Gastrointestinal Oncolology
Kohei shitara (@KoheiShitara) / X
Raghav Sundar (@sundar__raghav) / X
Kohei shitara (@KoheiShitara) / X
Daniel Catenacci (@DocCatenacci) / X
Kohei shitara (@KoheiShitara) / X
Kohei shitara on X: Suggesting synergy between anti-HER2 and PD1!! Higher N of pts on treatment (40.6% vs 28.5%) in 264 pts in efficacy population and 433 safety population (58.5 vs 48.1%)
Kohei shitara (@KoheiShitara) / X
ASCO #GI22: Gastric and esophageal cancers, HER2-targeted therapy, immunotherapy, ADCs
Kohei shitara (@KoheiShitara) / X
Kohei Shitara - Staff Doctor, Chiba, Japan
Kohei shitara (@KoheiShitara) / X
Raghav Sundar (@sundar__raghav) / X
Kohei shitara (@KoheiShitara) / X
WCGIC 2023
Recomendado para você
você pode gostar

© 2014-2024 galemiami.com. All rights reserved.